Literature DB >> 6894330

Skeletal muscle actin mRNA. Characterization of the 3' untranslated region.

M Shani, U Nudel, D Zevin-Sonkin, R Zakut, D Givol, D Katcoff, Y Carmon, J Reiter, A M Frischauf, D Yaffe.   

Abstract

Plasmids p749, p106, and p150 contain cDNA inserts complementary to rat skeletal muscle actin mRNA. Nucleotide sequence analysis indicates the following sequence relationships: p749 specifies codons 171 to 360; p150 specifies codons 357 to 374 together with 120 nucleotides of the 3'-non-translated region; p106 specifies the last actin amino acid codon, the termination codon and the entire 3' non-translated region. Plasmid p749 hybridized with RNA extracted from rat skeletal muscle, cardiac muscle, smooth (stomach) muscle, and from brain. It also hybridizes well with RNA extracted from skeletal muscle and brain of dog and chick. Plasmid p106 hybridized specifically with rat striated muscles (skeletal and cardiac muscle) mRNA but not with mRNA from rat stomach and from rat brain. It also hybridized to RNA extracted from skeletal muscle of rabbit and dog but not from chick. Thermal stability of the hybrids and sensitivity to S1 digestion also indicated substantial divergence between the 3' untranslated end of rat and dog skeletal muscle actins. The investigation shows that the coding regions of actin genes are highly conserved, whereas the 3' non-coding regions diverged considerably during evolution. Probes constructed from the 3' non-coding regions of actin mRNAs can be used to identify the various actin mRNA and actin genes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6894330      PMCID: PMC327223          DOI: 10.1093/nar/9.3.579

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  Non-identity of muscle and non-muscle actins.

Authors:  E Gruenstein; A Rich
Journal:  Biochem Biophys Res Commun       Date:  1975-05-19       Impact factor: 3.575

2.  Identification and characterization of multiple forms of actin.

Authors:  J I Garrels; W Gibson
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

3.  Chick cytoplasmic actin and muscle actin have different structural genes.

Authors:  R V Storti; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

4.  Protein synthesis and actin heterogeneity in calf muscle cells in culture.

Authors:  R G Whalen; G S Butler-Browne; F Gros
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

5.  Methylmercury as a reversible denaturing agent for agarose gel electrophoresis.

Authors:  J M Bailey; N Davidson
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

6.  3' non-coding region sequences in eukaryotic messenger RNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

7.  The primary structure of actin from rabbit skeletal muscle. Completion and analysis of the amino acid sequence.

Authors:  J H Collins; M Elzinga
Journal:  J Biol Chem       Date:  1975-08-10       Impact factor: 5.157

8.  Human heart and platelet actins are products of different genes.

Authors:  M Elzinga; B J Maron; R S Adelstein
Journal:  Science       Date:  1976-01-09       Impact factor: 47.728

9.  Actin microheterogeneity in chick embryo fibroblasts.

Authors:  P A Rubenstein; J A Spudich
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

10.  Nucleotide sequence of the rightward operator of phage lambda.

Authors:  T Maniatis; A Jeffrey; D G Kleid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

View more
  37 in total

1.  Inhibitory effects of interferon on the expression of genes regulated by platelet-derived growth factor.

Authors:  M Einat; D Resnitzky; A Kimchi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

2.  A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.

Authors:  P Gunning; J Leavitt; G Muscat; S Y Ng; L Kedes
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  Cloning of alpha 2 chain of type VI collagen and expression during mouse development.

Authors:  A Ibrahimi; B Bertrand; S Bardon; E Z Amri; P Grimaldi; G Ailhaud; C Dani
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

4.  Expression of human alpha-tubulin genes: interspecies conservation of 3' untranslated regions.

Authors:  N J Cowan; P R Dobner; E V Fuchs; D W Cleveland
Journal:  Mol Cell Biol       Date:  1983-10       Impact factor: 4.272

5.  There are approximately 20 actin gene in the human genome.

Authors:  S E Humphries; R Whittall; A Minty; M Buckingham; R Williamson
Journal:  Nucleic Acids Res       Date:  1981-10-10       Impact factor: 16.971

6.  The nucleotide sequence of myosin light chain (L-2A) mRNA from embryonic chicken cardiac muscle tissue.

Authors:  H H Arnold; M Krauskopf; M A Siddiqui
Journal:  Nucleic Acids Res       Date:  1983-02-25       Impact factor: 16.971

7.  cDNA recombinant plasmid complementary to mRNAs for light chains 1 and 3 of mouse skeletal muscle myosin.

Authors:  B Robert; A Weydert; M Caravatti; A Minty; A Cohen; P Daubas; F Gros; M Buckingham
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

8.  DNAase I sensitivity of genes expressed during myogenesis.

Authors:  Y Carmon; H Czosnek; U Nudel; M Shani; D Yaffe
Journal:  Nucleic Acids Res       Date:  1982-05-25       Impact factor: 16.971

9.  Expression and regulation of chicken actin genes introduced into mouse myogenic and nonmyogenic cells.

Authors:  A Seiler-Tuyns; J D Eldridge; B M Paterson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

10.  The development expression of the rat alpha-vascular and gamma-enteric smooth muscle isoactins: isolation and characterization of a rat gamma-enteric actin cDNA.

Authors:  K M McHugh; J L Lessard
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.